StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) in a research report report published on Thursday. The firm issued a hold rating on the stock. Several other research firms have also weighed in on SYRS. JMP Securities reduced their price objective on shares of Syros Pharmaceuticals from $16.00 to $15.00 in […]
StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) in a report published on Thursday. The brokerage issued a hold rating on the stock. A number of other equities analysts have also recently weighed in on the stock. JMP Securities reduced their price target on shares of Syros Pharmaceuticals from $16.00 to […]
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) has received a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year target price among brokerages that […]
Omega Therapeutics, Inc. (NASDAQ:OMGA – Get Rating) Director Richard A. Young sold 5,000 shares of the company’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $8.00, for a total transaction of $40,000.00. Following the completion of the transaction, the director now owns 744,118 shares in the […]
Omega Therapeutics, Inc. (NASDAQ:OMGA – Get Rating)’s share price traded up 5.9% on Monday . The company traded as high as $8.11 and last traded at $8.11. 50,382 shares were traded during mid-day trading, a decline of 44% from the average session volume of 90,671 shares. The stock had previously closed at $7.66. Wall Street […]